Authors:
Wadden, TA
Berkowitz, RI
Sarwer, DB
Prus-Wisniewski, R
Steinberg, C
Citation: Ta. Wadden et al., Benefits of lifestyle modification in the pharmacologic treatment of obesity - A randomized trial, ARCH IN MED, 161(2), 2001, pp. 218-227
Authors:
Wadden, TA
Berkowitz, RI
Womble, LG
Sarwer, DB
Arnold, ME
Steinberg, CM
Citation: Ta. Wadden et al., Effects of sibutramine plus orlistat in obese women following 1 year of treatment by sibutramine alone: A placebo-controlled trial, OBES RES, 8(6), 2000, pp. 431-437
Citation: Aj. Stunkard et Ri. Berkowitz, Low energy expenditure as a contributor to infant obesity - Reply to SE Roberts et al, AM J CLIN N, 71(1), 2000, pp. 155-156
Authors:
Wadden, TA
Silvestry, FE
Aber, JL
Berkowitz, RI
Foster, GD
Sutton, MGS
Citation: Ta. Wadden et al., Valvular heart disease in fenfluramine-phentermine-treated patients: A comparison with control patients, OBES RES, 7(3), 1999, pp. 309-310